Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Billionaire Stanley Druckenmiller Still Isn’t Buying Nvidia. But He Just Opened a Position in a Challenger That’s Soared More Than 100% This Year.

Nvidia was once Druckenmiller’s biggest holding.

Billionaire Stanley Druckenmiller Still Isn’t Buying Nvidia. But He Just Opened a Position in a Challenger That’s Soared More Than 100% This Year.

Published September 2, 2026 · Category: Finance

Overview

Stanley Druckenmiller was an early believer in artificial intelligence (AI) giant Nvidia (NASDAQ:NVDA), building up a significant stake back in 2022. In fact, the AI chip leader was the billionaire's biggest position for a good part of the following year. But in 2024, he sold all his Nvidia shares, saying the valuation had become rich. Druckenmiller didn't make a clean break, however, and instead expressed some regret. He even said he would consider buying Nvidia shares again at a lower valuation.

Since, Nvidia's valuation has declined -- it even reached a low of 17x forward earnings estimates earlier this year -- but so far this hasn't been enough to bring Druckenmiller back to this AI story. Instead, in the second quarter, Druckenmiller opened a new position in an Nvidia challenger that's seen its stock soar more than 100% this year. Let's check out the billionaire's move and consider whether it's one to follow.

Image source: Duquesne Family Office.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.